The 2020 AMR Benchmark compares what 30 pharmaceutical companies are doing to help bring antimicrobial resistance under control. Its assessment is based on a framework of 19 metrics across three Research Areas. Here you find the four key findings from 2020 as well as analyses of the companies' antimicrobial portfolios.

Back to top |